|
Scenario 8 A patient attends a consultation after commencing treatment with eptinezumab. They report good effect from treatment, with the number of headache days per month and MMD recorded in their headache diary decreasing from 25 headache days and 25 migraine days per month to 8 headache days and 6 MMD. Decreases in the patient’s HIT-6 and MIDAS are also reported. The patient is concerned that over time they may experience an increase in headache days and MMDs. What advice can the clinician provide this patient? |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.